lobbying_activities: 2786868

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2786868	406bdc94-acc9-4bdb-927d-d37a56a4a409	Q1	AKIN GUMP STRAUSS HAUER & FELD	682	UNITED STATES PHARMACOPEIAL CONVENTION	2022	first_quarter	PHA	Compounding; Drug Pricing; 21st Century Cures Act 2.0; COVID-19 pandemic response; Supply chain reform; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Cannabis; Infrastructure and budget reconciliation legislation.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2022-04-19T16:13:53-04:00